Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure
- Conditions
- Heart FailureDilated CardiomyopathyHeart Failure With Reduced Ejection Fraction
- Interventions
- Device: AlgisylDrug: Standard Medical Therapy
- First Posted Date
- 2017-03-17
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT03082508
An Open Label Rollover Trial for Patients Randomized to the Control Group of Study LSH-10-001
- Conditions
- CardiomyopathyHeart FailureDilated Cardiomyopathy
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02226679
- Locations
- 🇮🇹
A.O. Istituti Ospitalieri di Cremona"., Cremona, Italy
🇷🇴Emergency Clinic Center of The Army for The Cardiovascular Diseases, Bucharest, Romania
A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure
- Conditions
- Heart FailureDilated Cardiomyopathy
- Interventions
- Device: Algisyl-LVRDrug: Standard medical therapy
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT01311791
- Locations
- 🇦🇺
Heart Center at the Alfred, Melbourne, Victoria, Australia
🇩🇪Charité (Campus Virchov), Berlin, Germany
🇩🇪Charité - Universitätsmedizin Berlin (Campus Benjamin Franklin), Berlin, Germany
Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery
- Conditions
- Dilated Cardiomyopathy
- First Posted Date
- 2009-02-19
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00847964
- Locations
- 🇩🇪
Deutsche Herzzentrum München, München, Bavaria, Germany
🇩🇪Heart Center of the Technical University of Dresden, Dresden, Germany
🇵🇱John Paul II Hospital, Cracow, Poland
A Randomized Study to Demonstrate the Safety and Feasibility of Plexisyl-AF in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2007-11-22
- Last Posted Date
- 2011-03-10
- Lead Sponsor
- LoneStar Heart, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00562432
- Locations
- 🇩🇪
Heart Center Dresden, Dresden, Germany
🇩🇪Herzzentrum Leipzig GmbH, Leipzig, Germany
🇩🇪Deutsches Herzzentrum München, Munich, Germany